Table 2.
Individual proportional hazard models investigating the association between major adverse cardiovascular events and late gadolinium enhancement (Presence and Extent).
| Adjusted for LVEF, Sex, and Age | ||||||
|---|---|---|---|---|---|---|
| n | Endpoint | HR (95% CI) | Individual p Value | Overall p Value | ||
| Presence and extent | ||||||
| LGE | No | 23 | 4 (17.4%) | 1.00 | - | 0.002 |
| Any | 50 | 25 (50.0%) | 3.84 (1.10–13.40) | 0.035 | ||
| LGE | No | 23 | 4 (17.4%) | 1.00 | - | <0.001 |
| (0–7.5%) | 23 | 8 (34.8%) | 2.01 (0.50–8.03) | 0.323 | ||
| (7.5–15%) | 10 | 7 (70%) | 7.42 (1.76–31.3) | 0.006 | ||
| >15% | 17 | 10 (58.8%) | 9.02 (2.11–38.52) | 0.003 | ||
Values are n or n (%) unless otherwise indicated. p values are quoted for each model overall and for the individual components. LVEF, left ventricular ejection fraction; HR, hazard ratio; CI, confidence interval.